10x Genomics, Inc. (TXG) stock
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)
Close on Nov 16, 2026Market cap $7.16BP/E –Yield –
10x Genomics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
10x Genomics's profit margin for the twelve months ending Sep 30, 2026 was -10.8%. For fiscal 2025 it was -6.8%, against -29.9% the year before. The highest annual figure on record is -6.8% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6.8% | +23.1 |
| FY2024 | Dec 31, 2024 | -29.9% | +11.3 |
| FY2023 | Dec 31, 2023 | -41.2% | −9.1 |
| FY2022 | Dec 31, 2022 | -32.1% | −20.3 |
| FY2021 | Dec 31, 2021 | -11.9% | +169.7 |
| FY2020 | Dec 31, 2020 | -181.6% | −168.9 |
| FY2019 | Dec 31, 2019 | -12.7% | +64.2 |
| FY2018 | Dec 31, 2018 | -76.9% | −50.5 |
| FY2017 | Dec 31, 2017 | -26.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -12.9% | +5.5 |
| Q2 FY2026 | Jun 30, 2026 | -11.9% | −31.8 |
| Q1 FY2026 | Mar 31, 2026 | -8.9% | +13.3 |
| Q4 FY2025 | Dec 31, 2025 | -9.8% | +19.9 |
| Q3 FY2025 | Sep 30, 2025 | -18.4% | +5.1 |
| Q2 FY2025 | Jun 30, 2025 | 20.0% | +44.7 |
| Q1 FY2025 | Mar 31, 2025 | -22.2% | +20.3 |
| Q4 FY2024 | Dec 31, 2024 | -29.7% | −3.1 |
| Q3 FY2024 | Sep 30, 2024 | -23.6% | +36.9 |
| Q2 FY2024 | Jun 30, 2024 | -24.8% | +17.8 |
| Q1 FY2024 | Mar 31, 2024 | -42.5% | −4.7 |
| Q4 FY2023 | Dec 31, 2023 | -26.6% | −15.6 |
| Q3 FY2023 | Sep 30, 2023 | -60.5% | −28.5 |
| Q2 FY2023 | Jun 30, 2023 | -42.5% | +13.7 |
| Q1 FY2023 | Mar 31, 2023 | -37.8% | −0.7 |
| Q4 FY2022 | Dec 31, 2022 | -11.0% | +1.8 |
| Q3 FY2022 | Sep 30, 2022 | -32.0% | −18.3 |
| Q2 FY2022 | Jun 30, 2022 | -56.2% | −46.7 |
| Q1 FY2022 | Mar 31, 2022 | -37.0% | −26.1 |
| Q4 FY2021 | Dec 31, 2021 | -12.9% | +357.5 |
| Q3 FY2021 | Sep 30, 2021 | -13.7% | +78.0 |
| Q2 FY2021 | Jun 30, 2021 | -9.5% | +84.1 |
| Q1 FY2021 | Mar 31, 2021 | -10.9% | +18.5 |
| Q4 FY2020 | Dec 31, 2020 | -370.3% | −360.9 |
| Q3 FY2020 | Sep 30, 2020 | -91.7% | −76.0 |
| Q2 FY2020 | Jun 30, 2020 | -93.6% | −74.1 |
| Q1 FY2020 | Mar 31, 2020 | -29.4% | −22.6 |
| Q4 FY2019 | Dec 31, 2019 | -9.5% | +139.9 |
| Q3 FY2019 | Sep 30, 2019 | -15.7% | +26.2 |
| Q2 FY2019 | Jun 30, 2019 | -19.5% | −0.8 |
| Q1 FY2019 | Mar 31, 2019 | -6.8% | +50.5 |
| Q4 FY2018 | Dec 31, 2018 | -149.4% | – |
| Q3 FY2018 | Sep 30, 2018 | -41.9% | – |
| Q2 FY2018 | Jun 30, 2018 | -18.7% | – |
| Q1 FY2018 | Mar 31, 2018 | -57.3% | – |
See a number that looks wrong?